Biniyam G Demissei1, Gary Freedman2, Steven J Feigenberg2, John P Plastaras2, Amit Maity2, Amanda M Smith1, Caitlin McDonald1, Karyn Sheline1, Charles B Simone3, Lilie L Lin4, Joseph R Carver5, Peter Liu6, Liyong Zhang6, Justin E Bekelman2, Bonnie Ky7. 1. Department of Medicine, Division of Cardiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 2. Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland. 4. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. 5. Department of Medicine, Division of Cardiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 6. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. 7. Department of Medicine, Division of Cardiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: bonnie.ky@uphs.upenn.edu.
Abstract
PURPOSE: We characterized the early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy (RT) and evaluated their associations with radiation dose-volume metrics including mean heart dose (MHD), V5, and V30. METHODS AND MATERIALS: In a prospective longitudinal study of 87 patients with breast cancer, lung cancer, or mediastinal lymphoma treated with photon or proton thoracic RT, blood samples were obtained pre-RT and after completion of RT (median, 20 days; interquartile range [IQR], 1-35). High-sensitivity cardiac troponin T, N-terminal pro-B-type natriuretic peptide, placental growth factor (PIGF), and growth differentiation factor 15 (GDF-15) were measured. Associations between MHD, V5 and V30, and biomarker levels and associations between echocardiography-derived measures of cardiac function and biomarker levels were assessed in multivariable linear regression models. Analyses were performed according to the following subgroups: (1) breast cancer alone and (2) lung cancer and lymphoma combined. RESULTS: The median (IQR) estimates of MHD ranged from 1.3 Gy (0.9-2.4) in breast cancer (n = 60) to 6.8 Gy (5.4-10.2) in mediastinal lymphoma (n = 14) and 8.4 Gy (6.7-16.1) in lung cancer (n = 13) patients (P < .001). There were no significant increases in biomarker levels from pre-RT to post-RT in breast cancer. In lung cancer/lymphoma, PIGF increased from a median (IQR) of 20 ng/L (16-26) to 22 ng/L (16-30) (P = .005), and GDF-15 increased from 1171 ng/L (755-2493) to 1887 ng/L (903-3763) (P = .006). MHD, V5, and V30 were significantly associated with post-RT PIGF and GDF-15 levels in multivariable models. Changes in biomarkers were not significantly associated with changes in echocardiography-derived measures of cardiac function. CONCLUSION: Contemporary thoracic RT induces acute abnormalities in vascular and inflammatory biomarkers that are associated with radiation dose-volume metrics, particularly in lung cancer and mediastinal lymphoma. Long-term follow-up studies are needed to determine the impact of these changes on the development of overt cardiac disease.
PURPOSE: We characterized the early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy (RT) and evaluated their associations with radiation dose-volume metrics including mean heart dose (MHD), V5, and V30. METHODS AND MATERIALS: In a prospective longitudinal study of 87 patients with breast cancer, lung cancer, or mediastinal lymphoma treated with photon or proton thoracic RT, blood samples were obtained pre-RT and after completion of RT (median, 20 days; interquartile range [IQR], 1-35). High-sensitivity cardiac troponin T, N-terminal pro-B-type natriuretic peptide, placental growth factor (PIGF), and growth differentiation factor 15 (GDF-15) were measured. Associations between MHD, V5 and V30, and biomarker levels and associations between echocardiography-derived measures of cardiac function and biomarker levels were assessed in multivariable linear regression models. Analyses were performed according to the following subgroups: (1) breast cancer alone and (2) lung cancer and lymphoma combined. RESULTS: The median (IQR) estimates of MHD ranged from 1.3 Gy (0.9-2.4) in breast cancer (n = 60) to 6.8 Gy (5.4-10.2) in mediastinal lymphoma (n = 14) and 8.4 Gy (6.7-16.1) in lung cancer (n = 13) patients (P < .001). There were no significant increases in biomarker levels from pre-RT to post-RT in breast cancer. In lung cancer/lymphoma, PIGF increased from a median (IQR) of 20 ng/L (16-26) to 22 ng/L (16-30) (P = .005), and GDF-15 increased from 1171 ng/L (755-2493) to 1887 ng/L (903-3763) (P = .006). MHD, V5, and V30 were significantly associated with post-RT PIGF and GDF-15 levels in multivariable models. Changes in biomarkers were not significantly associated with changes in echocardiography-derived measures of cardiac function. CONCLUSION: Contemporary thoracic RT induces acute abnormalities in vascular and inflammatory biomarkers that are associated with radiation dose-volume metrics, particularly in lung cancer and mediastinal lymphoma. Long-term follow-up studies are needed to determine the impact of these changes on the development of overt cardiac disease.
Authors: Timo Lenderink; Christopher Heeschen; Stephan Fichtlscherer; Stefanie Dimmeler; Christian W Hamm; Andreas M Zeiher; Maarten L Simoons; Eric Boersma Journal: J Am Coll Cardiol Date: 2006-01-17 Impact factor: 24.094
Authors: Pehr A Lind; Robert Pagnanelli; Lawrence B Marks; Salvador Borges-Neto; Caroline Hu; Su Min Zhou; Kim Light; Patricia H Hardenbergh Journal: Int J Radiat Oncol Biol Phys Date: 2003-03-15 Impact factor: 7.038
Authors: Kevin R Kozak; Theodore S Hong; Patrick M Sluss; Elizabeth L Lewandrowski; Samir L Aleryani; Shannon M Macdonald; Noah C Choi; Torunn I Yock Journal: Lung Cancer Date: 2008-05-06 Impact factor: 5.705
Authors: Christopher Heeschen; Stefanie Dimmeler; Stephan Fichtlscherer; Christian W Hamm; Juergen Berger; Maarten L Simoons; Andreas M Zeiher Journal: JAMA Date: 2004-01-28 Impact factor: 56.272
Authors: Anthony F Yu; Alice Y Ho; Lior Z Braunstein; Maria E Thor; Katherine Lee Chuy; Anne Eaton; Elton Mara; Oren Cahlon; Chau T Dang; Kevin C Oeffinger; Richard M Steingart; Jennifer E Liu Journal: J Am Soc Echocardiogr Date: 2019-02-28 Impact factor: 5.251
Authors: Shahed N Badiyan; Lindsay L Puckett; Gregory Vlacich; Walter Schiffer; Lauren N Pedersen; Joshua D Mitchell; Carmen Bergom Journal: Curr Treat Options Oncol Date: 2022-09-10
Authors: Ioannis I Verginadis; Constantinos Koumenis; Alexandra D Dreyfuss; Denisa Goia; Khayrullo Shoniyozov; Swapnil V Shewale; Anastasia Velalopoulou; Susan Mazzoni; Harris Avgousti; Scott D Metzler; Paco E Bravo; Steven J Feigenberg; Bonnie Ky Journal: Clin Cancer Res Date: 2021-02-04 Impact factor: 13.801
Authors: Jennifer M T A Meessen; Daniela Cardinale; Fabio Ciceri; Maria Teresa Sandri; Maurizio Civelli; Barbara Bottazzi; GianFranco Cucchi; Elisabetta Menatti; Maurizio Mangiavacchi; Gianluigi Condorelli; Enrico Barbieri; Stefania Gori; Alessandro Colombo; Giuseppe Curigliano; Michela Salvatici; Paolo Pastori; Francesco Ghisoni; Alessandra Bianchi; Cristina Falci; Pietro Cortesi; Alberto Farolfi; Anna Monopoli; Carlo Milandri; Marco Bregni; Alessandra Malossi; Daniele Nassiacos; Claudio Verusio; Lidia Staszewsky; Roberto Leone; Deborah Novelli; Giovanna Balconi; Enrico B Nicolis; Maria Grazia Franzosi; Serge Masson; Cecilia Garlanda; Alberto Mantovani; Carlo M Cipolla; Roberto Latini Journal: ESC Heart Fail Date: 2020-05-01
Authors: Ting Xu; Qing H Meng; Susan C Gilchrist; Steven H Lin; Ruitao Lin; Tianlin Xu; Sarah A Milgrom; Saumil J Gandhi; Haijun Wu; Yu Zhao; Juan C Lopez-Mattei; Radhe Mohan; Zhongxing Liao Journal: Int J Radiat Oncol Biol Phys Date: 2021-07-21 Impact factor: 8.013
Authors: Stefan Stefanovic; Sebastian Berlit; Elena Sperk; Frederik Wenz; Christel Weiß; Frederik Trinkmann; Marc Sütterlin; Benjamin Tuschy Journal: Strahlenther Onkol Date: 2020-08-19 Impact factor: 3.621